Antipsychotic Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Antipsychotic stocks.

Antipsychotic Stocks Recent News

Date Stock Title
Nov 1 JNJ Stocks that hedge funds moved from long to short in August - Jefferies
Nov 1 JNJ Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase
Nov 1 JNJ J&J Medtech CIO Larry Jones resigns
Oct 31 JNJ The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction
Oct 31 JNJ Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
Oct 30 JNJ Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific
Oct 29 JNJ J&J and Lilly both unveil IL-23 inhibitor efficacy in Crohn’s disease
Oct 29 JNJ J&J to seek FDA approval after small-bore Impella heart pump hits trial goal
Oct 28 JNJ Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Oct 28 JNJ DOJ throws wrench into J&J bankruptcy plan to settle talc suits
Oct 28 JNJ J&J’s $8.2 Billion Talc Settlement Faces January Court Test
Oct 28 JNJ AbbVie to Acquire Aliada Therapeutics for $1.4 Billion
Oct 28 JNJ J&J Impella ECP heart pump meets primary endpoint
Oct 28 JNJ Johnson & Johnson's Tremfya Seeks Expanded Use Approval After It Shares Encouraging Late-Stage Study Data In Crohn's Disease
Oct 28 JNJ JNJ's subcutaneous Tremfya demonstrates efficacy in Crohn's
Oct 28 JNJ This Johnson & Johnson Insider Reduced Their Stake By 37%
Oct 28 JNJ TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn's disease
Antipsychotic

Antipsychotics, also known as neuroleptics, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay together with mood stabilizers in the treatment of bipolar disorder.The use of antipsychotics may result in many unwanted side effects such as involuntary movement disorders, gynecomastia, impotence, weight gain and metabolic syndrome. Long-term use can produce adverse effects such as tardive dyskinesia.
First-generation antipsychotics, known as typical antipsychotics, were first introduced in the 1950s, and others were developed until the early 1970s. Second-generation drugs, known as atypical antipsychotics, were introduced firstly with clozapine in the early 1970s followed by others. Both generations of medication block receptors in the brain for dopamine, but atypicals tend to act on serotonin receptors as well. Neuroleptic, originating from Greek: νεῦρον (neuron) and λαμβάνω (take hold of)—thus meaning "which takes the nerve"—refers to both common neurological effects and side effects.

Browse All Tags